托里消毒散治疗难治性先天性耳前瘘管感染体会

Experience on treatment of refractory congenital preauricular fistula infection with Tori disinfectant powder

目的:探讨托里消毒散加减治疗难治性先天性耳前瘘管感染期的疗效。方法:收集2013年至2015年间难治性先天性耳前瘘管感染期16例,男9例,女7例;平均年龄26岁。左耳11例,右耳5例,均为感染期已行切开排脓患者。均位于耳轮脚前方。结果:16例(16耳)患者, 3d治愈2耳,4d治愈5耳, 5d治愈11耳, 6d治愈13耳, 7d治愈16耳。结论:难治性耳前瘘管予托里消毒散加减口服可缩短病程,减轻患者换药痛苦,减少长时间服用抗生素产生耐药、胃肠肝肾损害等风险。

Objective: To investigate the effect of Toli Disinfection Powder(TXS) on refractory congenital preauricular fistula infection. Methods : From 2013 to 2015, 16 patients(9 males and 7 females) with refractory congenital preauricular fistula infection were collected, with an average age of 26 years. From 2013 to 2015, 16 cases of refractory congenital preauricular fistula infection were collected, including 9 males and 7 females, with an average age of 26 years. There were 11 cases in left ear and 5 cases in right ear. Are located in front of the earwheel foot. In front of your feet. Results: In 16 cases(16 ears), 2 ears were cured in 3 days, 2 ears were cured in 4 days, 5 ears were cured in 5 ears, 11 ears were cured in 6 days, 13 ears were cured in 6 days, 16 ears were cured in 7 days. Conclusion: The treatment of refractory preauricular fistula with Toxixuisan plus or minus oral administration can shorten the course of disease, alleviate the pain of changing medicine, reduce the risk of drug resistance, gastrointestinal liver and kidney damage and so on.